Morphocell Technologies to Present at 2023 Biotech Showcase
Montreal, January 10, 2023 - Morphocell is thrilled to announce that it will present its progress, platform and preclinical data at Biotech Showcase, one of the most important investor conferences, which is underway in San Francisco, CA.
Dr. Massimiliano Paganelli, the company's co-founder and CEO, will present Morpohocell's ReLiver technology and its applications for the treatment of severe liver disease. ReLiver is a unique stem cell-derived human engineered liver tissue capable of fully mature liver function. Dr. Paganelli will show efficacy and safety preclinical data supporting the ongoing development of ReLiver as an allogeneic cell therapy product to treat acute and acute-on-chronic liver failure. The presentation will be available to registered attendees from 9 am PST January 11
About Morphocell Technologies
Morphocell Technologies is a regenerative medicine company focused on the commercialization of innovative stem cell therapies aimed at treating severe liver disease. Morphocell is developing an extensive therapeutic platform based on its allogeneic pluripotent stem cell-derived engineered tissues for organ replacement therapy. Morphocell is currently raising its series A investment round.